As expected, CDMnOx@CM efficiently activated CD8+ T cells and promoted T cell survival within the tumor by accelerating the breakdown of H2O2 into O2, which decreased ROS levels in the TME [210]. This evidence concerns the gene CD8A and neoplasm.